Article
Chromatin Remodeling in Patient‐Derived Colorectal Cancer Models
21 Feb 2024
Abstract excerpt
Patient-Derived Organoids (PDO) and Xenografts (PDX) are the current gold standards for patient-derived models of cancer (PDMC). Nevertheless, how patient tumor cells evolve in these models and the impact on drug response remains unclear. Herein, the transcriptomic and chromatin accessibility landscapes of matched colorectal cancer (CRC) PDO, PDX, PDO-derived PDX (PDOX), and original patient tumors (PT) are...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
